BioCryst Pharmaceuticals
BCRX
#4784
Rank
ยฃ1.23 B
Marketcap
ยฃ5.95
Share price
2.60%
Change (1 day)
46.34%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ0.76 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total liabilities are ยฃ0.76 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BioCryst Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.76 B9.34%
2022-12-31ยฃ0.69 B35.56%
2021-12-31ยฃ0.51 B98.3%
2020-12-31ยฃ0.25 B148.51%
2019-12-31ยฃ0.10 B35.9%
2018-12-31ยฃ76.89 M9.98%
2017-12-31ยฃ69.91 M-2.26%
2016-12-31ยฃ71.53 M42.04%
2015-12-31ยฃ50.36 M28.04%
2014-12-31ยฃ39.33 M29.78%
2013-12-31ยฃ30.3 M-15.39%
2012-12-31ยฃ35.81 M-17.4%
2011-12-31ยฃ43.36 M52.34%
2010-12-31ยฃ28.46 M-17.63%
2009-12-31ยฃ34.55 M32.37%
2008-12-31ยฃ26.1 M-33.34%
2007-12-31ยฃ39.16 M62.1%
2006-12-31ยฃ24.16 M2.11%
2005-12-31ยฃ23.66 M1349.44%
2004-12-31ยฃ1.63 M77.17%
2003-12-31ยฃ0.92 M26.07%
2002-12-31ยฃ0.73 M-53.57%
2001-12-31ยฃ1.57 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ0.69 B-8.78%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.88 B 147.85%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.07 M-99.86%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ1.78 B 134.46%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ28.10 B 3,586.33%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ29.6 M-96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ47.41 B 6,118.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.89 B 17.44%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ12.38 M-98.38%๐Ÿ‡บ๐Ÿ‡ธ USA